Overview

Daikenchuto for Intestinal Dysmotility and Prevention of Postoperative Paralytic Ielus After Pancreaticoduodenectomy

Status:
Unknown status

Trial end date:
2016-08-01

Target enrollment:

Participant gender:

Summary

A multicenter randomized-controlled trial of daikenchuto (TJ-100), a traditional Japanese herbal medicine (Kampo), to investigate its effect on intestinal dysmotility and for the prevention of postoperative paralytic ileus.

Phase:

Phase 2

Details

Lead Sponsor:

Wakayama Medical University

Collaborator:

Epidemiological and Clinical Research Information Network

Treatments:

Pharmaceutical Solutions